and Markets has announced the addition of the "Medical Nanotechnology
Markets" report to their offering.
Nanotechnology has reached critical mass. Nowhere is this more evident than
in medicine. Rising medical costs, demands for less-invasive procedures and
pressures for immediate feedback of medical conditions, all point to nanotechnology
as offering a new approach in healthcare. According to U.S. National Science
Foundation estimates, by 2015 the annual global market for nano-related goods
and services will top $1 trillion, thus making it one of the fastest-growing
industries in history. Assuming that these figures prove to be accurate, nanotechnology
will emerge as a larger economic force than the combined telecommunications
and information technology industries at the beginning of the technology boom
of the late 1990s. This report covers the specific segments of the medical nanotechnology
markets, with particular emphasis on those segments where this emerging technology
is or shows the potential to be most impactful.
Nanotechnology, a field of science and technology that aims to control matter
at the atomic, molecular and macromolecular level, potentially has far-reaching
and paradigm-shifting implications for biology, drug discovery and medical technologies.
The discipline has already yielded healthcare discoveries that have been used
for drug delivery and diagnostic purposes. In this study, we describe various
nanotechnologies under development for biological and medical purposes and assess
their potential. Moreover, this analysis is arranged to provide an overview
of the regulatory issues faced by the medical nanotechnology industry and focuses
on how specific segments within the industry are poised for high future growth.